- Home
- ABSI vs BVS Comparison
ABSI vs BVS Comparison
Compare ABSI & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABSI | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.0M | 482.9M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ABSI | BVS |
|---|---|---|
| Price | $2.38 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $7.98 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 2.5M | 285.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.67 | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | $4,534,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $10.72 | $7.42 |
| Revenue Next Year | $313.07 | $6.46 |
| P/E Ratio | ★ N/A | $27.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $5.81 |
| 52 Week High | $5.23 | $11.25 |
Technical Indicators
Market Signals| Indicator | ABSI | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 50.32 |
| Support Level | N/A | $6.42 |
| Resistance Level | $3.29 | $9.01 |
| Average True Range (ATR) | 0.17 | 0.38 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 2.94 | 18.94 |
Price Performance
Historical ComparisonAbout ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.